Cogentis Therapeutics Overview

  • Founded
  • 2015

  • Status
  • Private

  • Employees
  • 4

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.18M

  • Investors
  • 3

Cogentis Therapeutics General Information


Developer of disease-modifying therapeutics intended to find cures for a number of neurodegenerative diseases. The company discovers and develops first-in-class therapeutics that prevent neurodegeneration and restore brain function to benefit the lives of those patients and their families, providing medical practitioners with treatments for Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy and more.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Delivery
Other Industries
Primary Office
  • 10668 Quarterstaff Road
  • Columbia, MD 21044
  • United States
+1 (443) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cogentis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 22-Sep-2021 $1.18M Completed Generating Revenue
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 01-Jan-2016 Completed Startup
1. Accelerator/Incubator 20-May-2015 Completed Startup
To view Cogentis Therapeutics’s complete valuation and funding history, request access »

Cogentis Therapeutics Executive Team (8)

Name Title Board Seat Contact Info
J. Kent Werner Ph.D Co-Founder & Chief Executive Officer
Christopher Burch Co-Founder & Chief Operating Officer
Benoît Renvoisé Ph.D Co-Founder
Ce Zhang Co-Founder
I-Hsun Wu Co-Founder
You’re viewing 5 of 8 executive team members. Get the full list »

Cogentis Therapeutics Board Members (2)

Name Representing Role Since
Greg Erman Self Board Member 000 0000
Laurent Balenci Ph.D Self Board Member & Advisor 000 0000
To view Cogentis Therapeutics’s complete board members history, request access »

Cogentis Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cogentis Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
OneStart Accelerator/Incubator 000 0000 000000 0
MassChallenge Accelerator/Incubator 000 0000 000000 0
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view Cogentis Therapeutics’s complete investors history, request access »